2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
2019 · European Heart Journal · 8,581 citations
https://doi.org/10.1093/eurheartj/ehz455
F
François Mach
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
24.1K
Citations
11
h-index
11
i10-index
François Mach is an academic researcher from University of Geneva. The author has contributed to research in topics: Pharmaceutical industry and healthcare & Lipoproteins and Cardiovascular Health & Meta-analysis and systematic reviews. The author has an h-index of 11, co-authored 40 publications.
Papers by this author
works2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
2021 · European Heart Journal · 5,787 citations
https://doi.org/10.1093/eurheartj/ehab484
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
2015 · European Heart Journal · 1,368 citations
https://doi.org/10.1093/eurheartj/ehv043
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
2015 · European Heart Journal · 1,368 citations
https://doi.org/10.1093/eurheartj/ehv043
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
2021 · European Journal of Preventive Cardiology · 485 citations
https://doi.org/10.1093/eurjpc/zwab154
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]
2019 · Atherosclerosis · 15 citations
https://doi.org/10.1016/j.atherosclerosis.2019.12.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat